UnknownPhase 2NCT03492866

Efficacy of Topical Gentamycin for Hereditary Hypotrichosis Simplex Caused by Nonsense Mutations in CDSN

Studying Hypotrichosis simplex

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Tel-Aviv Sourasky Medical Center
Principal Investigator: Liat Samuelov
Deprt. of Dermatology, Tel Aviv Sourasky MC
Intervention: Gentamicin Sulfate(drug)
Enrollment: 8 target
Eligibility: 18-120 years · All sexes
Timeline: 2018 – 2019

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03492866 on ClinicalTrials.gov

← Back to all trials